A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Global Incidence of Pertussis After the COVID-19 Pandemic
Tekijät: Gorringe, Andrew; Cavell, Breeze; Beard, Frank; Tsukada, Keiko; Otsuka, Nao; Fu, Pan; Moosa, Fahima; Fabianova, Katerina; Rodrigues, Carla; Bouchez, Valerie; Toubiana, Julie; Brisse, Sylvain; Dalby, Tine; He, Qiushui; Campbell, Helen; Hozbor, Daniela; Hariri, Susan; Pawloski, Lucia; Scanlon, Karen; Edwards, Kathryn
Kustantaja: JAMA Network
Julkaisuvuosi: 2025
Lehti: JAMA Network Open
Artikkelin numero: e2545963
Vuosikerta: 8
Numero: 12
eISSN: 2574-3805
DOI: https://doi.org/10.1001/jamanetworkopen.2025.45963
Julkaisun avoimuus kirjaamishetkellä: Avoimesti saatavilla
Julkaisukanavan avoimuus : Kokonaan avoin julkaisukanava
Verkko-osoite: https://doi.org/10.1001/jamanetworkopen.2025.45963
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/505793239
Importance Pertussis, or whooping cough, is caused by the Bordetella pertussis bacterium. It induces prolonged cough in all age groups and is a severe, life-threatening disease in young infants.
Observations In an online workshop organized by the International Bordetella Society on November 12, 2024, most participating countries reported very low pertussis incidence during and immediately following the COVID-19 pandemic. Since that time, many countries have seen large outbreaks of pertussis, particularly in adolescents. Before the pandemic, several countries, especially those using acellular pertussis vaccine in infants, reported circulating B pertussis isolates that lacked the acellular vaccine antigen pertactin. However, most recent isolates have been found to express this antigen. A rise in macrolide-resistant B pertussis isolates was also reported by several countries.
Conclusions and Relevance The potential for large outbreaks of pertussis highlights the importance of maintaining or increasing vaccine coverage in pregnancy and in infants and children. The data presented herein suggest a need for new pertussis vaccines that protect against both disease and infection and that reduce transmission.
Ladattava julkaisu This is an electronic reprint of the original article. |
Julkaisussa olevat rahoitustiedot:
The sponsor of this work was the International Bordetella Society, and the work was led by several members of the society. No additional funding was provided to the presenters for this work.